Newstral
Article
herald.co.zw on 2020-11-18 15:09
China’s Sinovac COVID-19 vaccine induces quick antibody responses: study
Related news
- China’s Sinovac COVID-19 vaccine induces quick antibody responses: studyherald.co.zw
- In clinical and real world trials, China’s Sinovac underperformsThe Economist
- Indonesia’s top Islamic body OKs China’s Sinovac vaccineSeattle Times
- China’s Sinovac vaccine efficacy 83.5 percent: Turkish researchersHurriyet Daily News
- Egypt approves China’s Sinovac coronavirus vaccine for emergency useherald.co.zw
- HTurkey says China’s Sinovac COVID Vaccine 91.25% Effective in Late Trialshamodia.com
- How China’s Sinovac compares with BioNTech’s mRNA vaccineThe Economist
- Egypt to produce China’s Sinovac COVID-19 vaccine in Juneherald.co.zw
- Coronavirus: oral CanSino shot gives a bigger antibody boost than third Sinovac jab, study findsSouth China Morning Post
- Coronavirus vaccine developed in China induces quick immune responseSouth China Morning Post
- Coronavirus latest: India nears 3 million cases; Indonesia and China’s Sinovac sign vaccine dealSouth China Morning Post
- SCovid-19: Singapore residents who took Sinovac turn to Pfizer to up their antibody counts, amid debate on booster shotsscmp.com
- Coronavirus: Brazil reports more modest 50.4 per cent efficacy for China’s Sinovac vaccineSouth China Morning Post
- China’s Sinovac Covid-19 Vaccine Is 50.4% Effective in Late-Stage Brazil Trialswsj.com
- BBusinessinsider.co.za | WHO approves China’s Sinovac jab – but SA’s regulator is still silent after 2 monthsbusinessinsider.co.za
- World Health Organization Approves China’s Sinovac Coronavirus Vaccine For Emergency UseForbes
- BBrazil Approves Import of China’s Sinovac Vaccinebloomberg.com
- Coronavirus: Singapore excludes China’s Sinovac jabs from national vaccination tally; South Korea cases surgeSouth China Morning Post
- China’s Sinovac Biotech says its Covid-19 vaccine appears safe for childrenSouth China Morning Post
- Coronavirus: China’s Sinovac investing US$60 million in Chile vaccine facilitySouth China Morning Post